Literature DB >> 10605011

Characterization of CD8+ T lymphocytes that persist after peripheral tolerance to a self antigen expressed in the pancreas.

C T Nugent1, D J Morgan, J A Biggs, A Ko, I M Pilip, E G Pamer, L A Sherman.   

Abstract

As a result of expression of the influenza hemagglutinin (HA) in the pancreatic islets, the repertoire of HA-specific CD8+ T lymphocytes in InsHA transgenic mice (D2 mice expressing the HA transgene under control of the rat insulin promoter) is comprised of cells that are less responsive to cognate Ag than are HA-specific CD8+ T lymphocytes from conventional mice. Previous studies of tolerance induction involving TCR transgenic T lymphocytes suggested that a variety of different mechanisms can reduce avidity for Ag, including altered cell surface expression of molecules involved in Ag recognition and a deficiency in signaling through the TCR complex. To determine which, if any, of these mechanisms pertain to CD8+ T lymphocytes within a conventional repertoire, HA-specific CD8+ T lymphocytes from B10.D2 mice and B10.D2 InsHA transgenic mice were compared with respect to expression of cell surface molecules, TCR gene utilization, binding of tetrameric KdHA complexes, lytic mechanisms, and diabetogenic potential. No evidence was found for reduced expression of TCR or CD8 by InsHA-derived CTL, nor was there evidence for a defect in triggering lytic activity. However, avidity differences between CD8+ clones correlated with their ability to bind KdHA tetramers. These results argue that most of the KdHA-specific T lymphocytes in InsHA mice are not intrinsically different from KdHA-specific T lymphocytes isolated from conventional animals. They simply express TCRs that are less avid in their binding to KdHA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10605011     DOI: 10.4049/jimmunol.164.1.191

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Contribution of TCR signaling strength to CD8+ T cell peripheral tolerance mechanisms.

Authors:  Trevor R F Smith; Gregory Verdeil; Kristi Marquardt; Linda A Sherman
Journal:  J Immunol       Date:  2014-08-25       Impact factor: 5.422

2.  Multiple costimulatory modalities enhance CTL avidity.

Authors:  James W Hodge; Mala Chakraborty; Chie Kudo-Saito; Charlie T Garnett; Jeffrey Schlom
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

3.  Lentiviral calnexin-modified dendritic cells promote expansion of high-avidity effector T cells with central memory phenotype.

Authors:  Bei Wang; Shuhong Han; Lily Lien; Lung-Ji Chang
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

4.  Transnuclear TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent antitumor activity.

Authors:  Stephanie K Dougan; Michael Dougan; Jun Kim; Jacob A Turner; Souichi Ogata; Hyun-Il Cho; Rudolf Jaenisch; Esteban Celis; Hidde L Ploegh
Journal:  Cancer Immunol Res       Date:  2013-08       Impact factor: 11.151

Review 5.  Self-tolerance and the composition of T cell repertoire.

Authors:  L A Sherman; D J Morgan; C T Nugent; F J Hernandez; H T Kreuwel; A Murtaza; A Ko; J Biggs
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

6.  Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes.

Authors:  Laura A Johnson; Bianca Heemskerk; Daniel J Powell; Cyrille J Cohen; Richard A Morgan; Mark E Dudley; Paul F Robbins; Steven A Rosenberg
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

7.  Optimal T-cell receptor affinity for inducing autoimmunity.

Authors:  Sabrina Koehli; Dieter Naeher; Virginie Galati-Fournier; Dietmar Zehn; Ed Palmer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-19       Impact factor: 11.205

8.  Why Do CD8+ T Cells become Indifferent to Tumors: A Dynamic Modeling Approach.

Authors:  Colin Campbell; Ranran Zhang; Jeremy S Haley; Xin Liu; Thomas Loughran; Todd D Schell; Réka Albert; Juilee Thakar
Journal:  Front Physiol       Date:  2011-07-11       Impact factor: 4.566

9.  Functional differences between low- and high-affinity CD8(+) T cells in the tumor environment.

Authors:  Rinke Bos; Kristi L Marquardt; Jocelyn Cheung; Linda A Sherman
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

10.  Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection.

Authors:  Sarah Enouz; Lucie Carrié; Doron Merkler; Michael J Bevan; Dietmar Zehn
Journal:  J Exp Med       Date:  2012-09-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.